Accordingly, it appears that the transition of vasopressin-induced cardiac hypertrophy to heart failure may also occur due to the development of oxidative stress as a consequence of both Ang II and norepinephrine released from endogenous RAS and sympathetic nerve endings in the heart. The gene discussed is AGT; the disease is cardiac hypertrophy.